Assessment of test-retest reproducibility by [18F]Bavarostat for PET imaging of HDAC6
The test-retest variability of [<sup>18</sup>F]Bavarostat V<sub>T</sub> values demonstrated favorable results for a one-month scan interval, comparable to the reported values.
Authors
- Jean‐Dominique Gallezot (ORCID: https://orcid.org/0000-0003-0399-8374)
- Nabeel Nabulsi (ORCID: https://orcid.org/0000-0001-8129-0051)
- Richard E. Carson (ORCID: https://orcid.org/0000-0002-9338-7966)
- Robin Bonomi
- Mika Naganawa (ORCID: https://orcid.org/0000-0002-4408-2621)
- Yiyun Huang
- Jiwei Gu (ORCID: https://orcid.org/0000-0002-4908-7544)
- Koen Van Laere (ORCID: https://orcid.org/0000-0001-5200-7245)
- David Matuskey (ORCID: https://orcid.org/0000-0001-7508-6572)
- Hong Gao (ORCID: https://orcid.org/0009-0006-9622-1837)
- Michel Koole
- Ming‐Qiang Zheng
- Swanee Jacutin-Porte
Institutions
- Yale Cancer Center (US)
- Yale University (US)
- KU Leuven (BE)
Publication Details
- Journal
- EJNMMI Research
- Published
- 2025-06-21
- DOI
- https://doi.org/10.1186/s13550-025-01268-w
- Citations
- 2
- Primary Topic
- Histone Deacetylase Inhibitors Research
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- Yale University
- National Institutes of Health
- National Institute of Mental Health